137 related articles for article (PubMed ID: 8828723)
1. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension.
Johansen S; Rask-Pedersen E; Prause JU
Acta Ophthalmol Scand; 1996 Jun; 74(3):259-64. PubMed ID: 8828723
[TBL] [Abstract][Full Text] [Related]
2. A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension.
Johansen S; Rask-Pedersen E; Prause JU
Acta Ophthalmol Scand; 1996 Jun; 74(3):253-8. PubMed ID: 8828722
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of prednisolone in rabbits: comparison of a high-viscosity gel and an aqueous suspension--single- and repeated applications.
Johansen S; Rask-Pedersen E; Prause JU
Adv Exp Med Biol; 1994; 350():399-402. PubMed ID: 8030508
[No Abstract] [Full Text] [Related]
4. A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations.
Schoenwald RD; Boltralik JJ
Invest Ophthalmol Vis Sci; 1979 Jan; 18(1):61-6. PubMed ID: 759386
[TBL] [Abstract][Full Text] [Related]
5. Comparative corneal penetration of prednisolone sodium phosphate and prednisolone acetate in NZW rabbits.
Musson DG; Bidgood AM; Olejnik O
J Ocul Pharmacol; 1991; 7(2):175-82. PubMed ID: 1919274
[TBL] [Abstract][Full Text] [Related]
6. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
Zhang L; Zhang J; Wang L; Xia H
Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
[TBL] [Abstract][Full Text] [Related]
7. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
[TBL] [Abstract][Full Text] [Related]
8. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.
Proksch JW; Granvil CP; Siou-Mermet R; Comstock TL; Paterno MR; Ward KW
J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955
[TBL] [Abstract][Full Text] [Related]
9. Biological equivalence of ophthalmic prednisolone acetate suspensions.
Kupferman A; Leibowitz HM
Am J Ophthalmol; 1976 Jul; 82(1):109-13. PubMed ID: 937444
[TBL] [Abstract][Full Text] [Related]
10. Ocular bioavailability of topical prednisolone preparations.
Olejnik O; Weisbecker CA
Clin Ther; 1990; 12(1):2-11. PubMed ID: 2328525
[TBL] [Abstract][Full Text] [Related]
11. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
[TBL] [Abstract][Full Text] [Related]
12. Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison.
Naageshwaran V; Ranta VP; Toropainen E; Tuomainen M; Gum G; Xie E; Bhoopathy S; Urtti A; Del Amo EM
Int J Pharm; 2022 Mar; 615():121515. PubMed ID: 35091006
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel.
Kupferman A; Ryan WJ; Leibowitz HM
Arch Ophthalmol; 1981 Nov; 99(11):2028-9. PubMed ID: 7295153
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic bioequivalence of steroid/antibiotic combination formulations.
Schoenwald RD; Harris RG; Turner D; Knowles W; Chien DS
Biopharm Drug Dispos; 1987; 8(6):527-48. PubMed ID: 3427210
[TBL] [Abstract][Full Text] [Related]
15. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
Zhang J; Wang L; Gao C; Zhang L; Xia H
J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the ocular bioavailability of topical tobramycin with use of a collagen shield.
Chen CC; Takruri H; Duzman E
J Cataract Refract Surg; 1993 Mar; 19(2):242-5. PubMed ID: 8487167
[TBL] [Abstract][Full Text] [Related]
18. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.
Amar T; Caillaud T; Elena PP
Curr Eye Res; 2008 Feb; 33(2):149-58. PubMed ID: 18293185
[TBL] [Abstract][Full Text] [Related]
19. Penetration of synthetic corticosteroids into human aqueous humour.
McGhee CN; Watson DG; Midgley JM; Noble MJ; Dutton GN; Fern AI
Eye (Lond); 1990; 4 ( Pt 3)():526-30. PubMed ID: 2209921
[TBL] [Abstract][Full Text] [Related]
20. Corneal and intraocular penetration of topical and subconjunctival fusidic acid.
Taylor PB; Burd EM; Tabbara KF
Br J Ophthalmol; 1987 Aug; 71(8):598-601. PubMed ID: 3651375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
